We are live on ! Find out more
DALS

DA32 Life Science Tech Acquisition Corp. Class A Common Stock
DALS

Delisted

DALS was delisted on the 28th of July, 2023.

Back to rankings

43 hedge funds and large institutions have $151M invested in DA32 Life Science Tech Acquisition Corp. Class A Common Stock in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

8% more capital invested

Capital invested by funds: $140M → $151M (+$11.3M)

4% less funds holding

Funds holding: 45 → 43 (-2)

17% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 6

20% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 5

Holders
43
Holders Change
-2
Holders Change %
-4.44%
% of All Funds
0.74%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
5
Reduced
6
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
MP
Mangrove Partners
Connecticut
+$3.66M
2
CSS
Cubist Systematic Strategies
Connecticut
+$2.96M
3
CF
Cantor Fitzgerald
New York
+$1.11M
4
WAM
Wolverine Asset Management
Illinois
+$1.05M
5
HCM
Highbridge Capital Management
New York
+$884K

Top Sellers

Rank Fund Capital Flow
1
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$4.84M
2
WRBC
W.R. Berkley Corp
Connecticut
-$1.52M
3
CL
CSS LLC
Illinois
-$1.45M
4
Millennium Management
Millennium Management
New York
-$739K
5
MF
Magnetar Financial
Illinois
-$553K
Name Holding Trade Value Shares
Change 		Change in
Stake
WAM
26
Wolverine Asset Management
Illinois
$1.06M +$1.05M +107,999 +10,800%
CIM
27
Cowen Investment Management
New York
$973K – – –
SCM
28
Segantii Capital Management
Hong Kong
$971K – – –
JP Morgan Chase
29
JP Morgan Chase
New York
$964K -$491K -50,500 -34%
HCM
30
Highbridge Capital Management
New York
$881K +$884K +90,891 New
ETH
31
Exos TFP Holdings
New York
$737K +$736K +75,704 New
FTCM
32
Fir Tree Capital Management
New York
$734K – – –
ACA
33
Arena Capital Advisors
California
$671K – – –
KIM
34
Karpus Investment Management
New York
$525K +$524K +53,950 New
COPPSERS
35
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$487K – – –
SCM
36
Soleus Capital Management
Connecticut
$487K – – –
D.E. Shaw & Co
37
D.E. Shaw & Co
New York
$446K – – –
PSC
38
Piper Sandler & Co
Minnesota
$243K – – –
HF
39
HRT Financial
New York
$164K – – –
SFM
40
Spartan Fund Management
Canada
$144K – – –
PHK
41
Point72 Hong Kong
Hong Kong
$118K -$4.12K -424 -3%
EC
42
Elequin Capital
New York
$14K +$14.4K +1,483 New
UBS Group
43
UBS Group
Switzerland
$2K – – –
Alyeska Investment Group
44
Alyeska Investment Group
Illinois
– -$4.84M -500,000 Closed
WRBC
45
W.R. Berkley Corp
Connecticut
– -$1.52M -157,016 Closed
CL
46
CSS LLC
Illinois
– -$1.45M -149,412 Closed
SSA
47
Schonfeld Strategic Advisors
New York
– -$130K -13,389 Closed
CCMU
48
Cheyne Capital Management (UK)
United Kingdom
– -$97K -10,000 Closed
1
2

DALS Hedge Fund Activity: Q3 2022 in Review

43 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in DA32 Life Science Tech Acquisition Corp. Class A Common Stock (DALS) for Q3 2022, worth a combined $151M — up 8.1% from $140M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of DALS and 4 opened new positions — a net loss of 1 holder — while 6 trimmed existing stakes and 5 added.

The largest buyer was Mangrove Partners, adding an estimated $3.66M. The largest seller was Alyeska Investment Group, exiting entirely with an estimated $4.84M sold.

  • 43 institutional investors held DA32 Life Science Tech Acquisition Corp. Class A Common Stock (DALS) as of Q3 2022, down from 45 in Q2 2022.
  • Funds reported $151M of DA32 Life Science Tech Acquisition Corp. Class A Common Stock stock for Q3 2022, up 8.1% quarter-over-quarter.
  • 4 funds opened new DA32 Life Science Tech Acquisition Corp. Class A Common Stock positions in Q3 2022 and 5 closed out, a net change of -1 holder.
  • The largest DA32 Life Science Tech Acquisition Corp. Class A Common Stock buyer in Q3 2022 was Mangrove Partners, an estimated $3.66M added.
  • The largest DA32 Life Science Tech Acquisition Corp. Class A Common Stock seller in Q3 2022 was Alyeska Investment Group, an estimated $4.84M sold.

Based on aggregated 13F filings for Q3 2022.